27 June – 03 July 2016
What does Brexit mean for the research community?
Great Britain and the EU are closely tied together in the field of research – in the exchange of scientists, in financing and in setting common standards. What now? Find source
FDA approves first pill to treat all forms of hepatitis C
Federal health officials on Tuesday approved the first pill to treat all major forms of hepatitis C, the latest in a series of drug approvals that have reshaped treatment of the liver-destroying virus. Find source
Science academies blast US government’s planned research-ethics reforms
The US government’s proposed overhaul of regulations that govern research with human subjects is flawed and should be withdrawn, an independent advisory panel said. Find source
Zika vaccine protects mice, but may increase risk of dengue
Just one dose of a newly developed Zika vaccine gives mice complete immunity to the disease but the vaccine might put people at greater risk from another more common virus, dengue. But the good news is that a more precisely targeted vaccine may eventually work for both diseases. Find source
New technology could deliver drugs to brain injuries
A new study led by scientists at the Sanford Burnham Prebys Medical Discovery Institute (SBP) describes a technology that could lead to new therapeutics for traumatic brain injuries. The discovery, published in Nature Communications, provides a means of homing drugs or nanoparticles to injured areas of the brain. Find source
